|
1
|
Zelt JGE, Sugarman J, Weatherald J,
Partridge ACR, Liang JC, Swiston J, Brunner N, Chandy G, Stewart
DJ, Contreras-Dominguez V, et al: Mortality trends in pulmonary
arterial hypertension in Canada: A temporal analysis of survival
per ESC/ERS guideline era. Eur Respir J. 59:21015522022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boucly A, Weatherald J, Savale L, Jaïs X,
Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, et
al: Risk assessment, prognosis and guideline implementation in
pulmonary arterial hypertension. Eur Respir J. 50:17008892017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raina A and Humbert M: Risk assessment in
pulmonary arterial hypertension. Eur Respir Rev. 25:390–398. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galie N, Humbert M, Vachiery JL, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A,
Beghetti M, et al: 2015 ESC/ERS Guidelines for the diagnosis and
treatment of pulmonary hypertension: The Joint Task Force for the
Diagnosis and Treatment of Pulmonary Hypertension of the European
Society of Cardiology (ESC) and the European Respiratory Society
(ERS): Endorsed by: Association for European Paediatric and
Congenital Cardiology (AEPC), International Society for Heart and
Lung Transplantation (ISHLT). Eur Heart J. 37:67–119. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chin KM, Sitbon O, Doelberg M, Feldman J,
Gibbs JSR, Grünig E, Hoeper MM, Martin N, Mathai SC, McLaughlin VV,
et al: Three-Versus two-drug therapy for patients with newly
diagnosed pulmonary arterial hypertension. J Am Coll Cardiol.
78:1393–1403. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dumas SJ, Bru-Mercier G, Courboulin A,
Quatredeniers M, Rücker-Martin C, Antigny F, Nakhleh MK, Ranchoux
B, Gouadon E, Vinhas MC, et al: NMDA-Type glutamate receptor
activation promotes vascular remodeling and pulmonary arterial
hypertension. Circulation. 137:2371–2389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caruso P, Dunmore BJ, Schlosser K, Schoors
S, Dos Santos C, Perez-Iratxeta C, Lavoie JR, Zhang H, Long L,
Flockton AR, et al: Identification of MicroRNA-124 as a major
regulator of enhanced endothelial cell glycolysis in pulmonary
arterial hypertension via PTBP1 (Polypyrimidine Tract Binding
Protein) and pyruvate kinase M2. Circulation. 136:2451–2467. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Wang D, Li M, Plecitá-Hlavatá L,
D'Alessandro A, Tauber J, Riddle S, Kumar S, Flockton A, McKeon BA,
et al: Metabolic and proliferative state of vascular adventitial
fibroblasts in pulmonary hypertension is regulated through a
MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein
1)/pyruvate kinase muscle axis. Circulation. 136:2468–2485. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quatredeniers M, Nakhleh MK, Dumas SJ,
Courboulin A, Vinhas MC, Antigny F, Phan C, Guignabert C,
Bendifallah I, Vocelle M, et al: Functional interaction between
PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell
proliferation and migration in pulmonary arterial hypertension. Am
J Physiol Lung Cell Mol Physiol. 316:L445–L455. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Savai R, Al-Tamari HM, Sedding D,
Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N,
Grimminger F, Seeger W, et al: Pro-proliferative and inflammatory
signaling converge on FoxO1 transcription factor in pulmonary
hypertension. Nat Med. 20:1289–1300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiao Y, Peng H, Hong C, Chen Z, Deng X,
Wang A, Yang F, Yang L, Chen C and Qin X: PDGF promotes the Warburg
effect in pulmonary arterial smooth muscle cells via activation of
the PI3K/AKT/mTOR/HIF-1α signaling pathway. Cell Physiol Biochem.
42:1603–1613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tamada M, Suematsu M and Saya H: Pyruvate
kinase M2: Multiple faces for conferring benefits on cancer cells.
Clin Cancer Res. 18:5554–5561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Sheng XJ, Qin YY, Zhu S, Wu QX,
Jia L, Meng N, He YT and Yan GR: TBC1D8 amplification drives
tumorigenesis through metabolism reprogramming in ovarian cancer.
Theranostics. 9:676–690. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo
F, Lyssiotis CA, Aldape K, Cantley LC and Lu Z: ERK1/2-dependent
phosphorylation and nuclear translocation of PKM2 promotes the
Warburg effect. Nat Cell Biol. 14:1295–1304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong K and Li W: Shikonin, a Chinese
plant-derived naphthoquinone, induces apoptosis in hepatocellular
carcinoma cells through reactive oxygen species: A potential new
treatment for hepatocellular carcinoma. Free Radic Biol Med.
51:2259–2271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia L, Zhu Z, Li H and Li Y: Shikonin
inhibits proliferation, migration, invasion and promotes apoptosis
in NCI-N87 cells via inhibition of PI3K/AKT signal pathway. Artif
Cells Nanomed Biotechnol. 47:2662–2669. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Yao X, Zhang Y and Tang J:
Synthesis, biological function and evaluation of Shikonin in cancer
therapy. Fitoterapia. 134:329–339. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao X, Zhu Y, Hu J, Jiang L, Li L, Jia S
and Zen K: Shikonin inhibits tumor growth in mice by suppressing
pyruvate kinase M2-mediated aerobic glycolysis. Sci Rep.
8:145172018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Archer SL: Pyruvate kinase and Warburg
metabolism in pulmonary arterial hypertension: Uncoupled glycolysis
and the cancer-like phenotype of pulmonary arterial hypertension.
Circulation. 136:2486–2490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ
and Li YJ: Involvement of asymmetric dimethylarginine and Rho
kinase in the vascular remodeling in monocrotaline-induced
pulmonary hypertension. Vascul Pharmacol. 53:223–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu D, Shang X, Ni Z and Shi G: Shikonin
inhibits inflammation and chondrocyte apoptosis by regulation of
the PI3K/Akt signaling pathway in a rat model of osteoarthritis.
Exp Ther Med. 12:2735–2740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu D, Xiao Y, Zhou B, Gao S, Li L, Zhao
L, Chen W, Dai B, Li Q, Duan H, et al: PKM2-dependent glycolysis
promotes skeletal muscle cell pyroptosis by activating the NLRP3
inflammasome in dermatomyositis/polymyositis. Rheumatology
(Oxford). 60:2177–2189. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zuo W, Liu N, Zeng Y, Xiao Z, Wu K, Yang
F, Li B, Song Q, Xiao Y and Liu Q: Luteolin ameliorates
experimental pulmonary arterial hypertension via suppressing
Hippo-YAP/PI3K/AKT signaling pathway. Front Pharmacol.
12:6635512021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thenappan T, Ormiston ML, Ryan JJ and
Archer SL: Pulmonary arterial hypertension: Pathogenesis and
clinical management. BMJ. 360:j54922018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Imai K, Kato H, Taguchi Y and Umeda M:
Biological effects of Shikonin in human gingival fibroblasts via
ERK 1/2 signaling pathway. Molecules. 24:35422019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu B, Jin J, Zhang Z, Zuo L, Jiang M and
Xie C: Shikonin exerts antitumor activity by causing mitochondrial
dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α
signaling pathway. Biochem Cell Biol. 97:397–405. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HJ, Hwang KE, Park DS, Oh SH, Jun HY,
Yoon KH, Jeong ET, Kim HR and Kim YS: Shikonin-induced necroptosis
is enhanced by the inhibition of autophagy in non-small cell lung
cancer cells. J Transl Med. 15:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi S and Cao H: Shikonin promotes
autophagy in BXPC-3 human pancreatic cancer cells through the
PI3K/Akt signaling pathway. Oncol Lett. 8:1087–1089. 2014.
View Article : Google Scholar : PubMed/NCBI
|
